Large Cap Biopharma in Focus: Core Positions…Risk OFF…Updates
10/09/19 Better tape today but a lot of random churning and tactical trading, biopharma under siege? NASDAQ up 1.17%. Talk about mini-deal with China. Large cap leaders with IBB flat: REGN MRK BMY. Mid caps weak with XBI down 0.63%. JNJ woes continue with $8B verdict on Risperdal, stock down 2%...
Biotech Snapshot: Bears Are Digging In…Update-2… Upside Reversal
Update-2 10/4 Broad Rally day: all major averages up 1.4%, NAZ at 7982. Risk back on. But biotech lags major indices IBB up 0.75%, XBI up 0.21% to $76.82. Better trade for biotech has been large caps: ABBV, AMGN, MRK,RHHBY VRTX. Mid-cap movers: BLUE up 3.97%, GWPH up 5.22%, NKTR up 4.2%, SRPT...
Biopharma Stocks Mired in Macro-Risk Off…Update-2…”Future of Biotech” from Barrons’s
With biotech in a funk this timely article from Barron's should help. Barron's to the Rescue: Future of Biotech, article offers picks from a new Roundtable (above link may not open because requires subscription) Some of the picks ASND, MDCO,MGTX,NVTA,RGNX, SRPT, VRTX ========= Update-2 9/28...
What Did I Miss While I was on Vacation in September: Biotech Wrap-Up in a Sideways Market…Update-1
Update-1 A bit of a sell-off on end of week option expirations and cancellation of China visit to farm Bureau in MT. NAZ down 0.8%, S&P down 0.5%. Less reaction to China news now? Can biotech rally as contrian play to tech and industrials? tape in biotech was better than overall market....